Severe bilateral amyotrophic neuralgia associated with major dysphagia secondary to acute hepatitis E

F1000Research

Volumn 2, Issue , 2014, Pages

  Moisset, Xavier ^a,b   Vitello, Nicolas ^a,c   Bicilli, Elodie ^a   Courtin, Romain ^a   Ferrier, Anna ^a   Taithe, Frederic ^a   Lahaye, Clément ^a   Hssain, Ali Ait ^a   Garrouste, Cyril ^a,c   Pierre, Clavelou ^a,b,c  

^a SERVICE DE RHUMATOLOGIE   (France)

^b Neuro Dol Inserm U1107 Douleur Trigéminale et Migraine ^*  (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN; RIBAVIRIN; VIRUS RNA;

ABDOMINAL PAIN; ADULT; AMYOTROPHIC NEURALGIA; ARM WEAKNESS; ARTICLE; ARTIFICIAL FEEDING; BLOOD SAMPLING; CASE REPORT; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DYSPHAGIA; ELECTROMYOGRAM; ENZYME BLOOD LEVEL; FEEDING APPARATUS; FOLLOW UP; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HYPOPHONIA; MALE; MUSCLE STRENGTH; NASOGASTRIC TUBE; NAUSEA; NERVE CONDUCTION; NONHUMAN; PERIPHERAL NEUROPATHY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; SHOULDER PAIN; SPEECH DISORDER;

EID: 84914817536     PISSN: 20461402     EISSN: 1759796X     Source Type: Journal    
DOI: 10.12688/f1000research.2-259.v2     Document Type: Article

References (9)

1. Kamar N Bendall R Legrand-Abravanel F: Hepatitis E. Lancet. 2012;379(9835):2477-2488. 22549046 10.1016/S0140-6736(11)61849-7
2. Van Alfen N: Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol. 2011;7(6):315-322. 21556032 10.1038/nrneurol.2011.62
3. Van Alfen N Van Engelen BG Hughes RA: Treatment for idiopathic and hereditary neuralgic amyotrophy (brachial neuritis). Cochrane Database Syst Rev. 2009;8(3):CD006976. 19588414 10.1002/14651858.CD006976.pub2
4. Johnson NE Petraglia AL Huang JH: Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin. Muscle Nerve. 2011;44(2):304-305. 21717467 10.1002/mus.22100
5. Moriguchi K Miyamoto K Takada KM: Four cases of anti-ganglioside antibody-positive neuralgic amyotrophy with good response to intravenous immunoglobulin infusion therapy. J Neuroimmunol. 2011;238(1-2):107-109. 21872943 10.1016/j.jneuroim.2011.08.005
6. Naito K Fukushima K Suzuki SM: Intravenous immunoglobulin (IVIg) with methylprednisolone pulse therapy for motor impairment of neuralgic amyotrophy: clinical observations in 10 cases. Intern Med. 2012;51(12):1493-1500. 22728480 10.2169/internalmedicine.51.7049
7. Cheung MC Maguire J Carey IM: Review of the neurological manifestations of hepatitis E infection. Ann Hepatol. 2012;11(5):618-622. 22947521
8. Luciano L Martel C De Pina JJ: Genotype 3f predominance in symptomatic acute autochthonous hepatitis E: a short case series in south-eastern France. Clin Res Hepatol Gastroenterol. 2012;36(3):e54-5. 22521756 10.1016/j.clinre.2012.03.009
9. Abbas Z Afzal R: Hepatitis E: when to treat and how to treat. Antivir Ther. 2013. 24192696 10.3851/IMP2705